Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001558370-23-001643
Filing Date
2023-02-21
Accepted
2023-02-21 16:25:48
Documents
141
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A aytu-20220930x10qa.htm   iXBRL 10-Q/A 1978194
2 EX-31.1 aytu-20220930xex31d1.htm EX-31.1 15237
3 EX-31.2 aytu-20220930xex31d2.htm EX-31.2 14037
4 EX-32 aytu-20220930xex32.htm EX-32 14770
5 GRAPHIC aytu-20220930x10qa001.jpg GRAPHIC 3651
  Complete submission text file 0001558370-23-001643.txt   12424165

Data Files

Seq Description Document Type Size
6 EX-101.SCH aytu-20220930.xsd EX-101.SCH 112189
7 EX-101.CAL aytu-20220930_cal.xml EX-101.CAL 84395
8 EX-101.DEF aytu-20220930_def.xml EX-101.DEF 392116
9 EX-101.LAB aytu-20220930_lab.xml EX-101.LAB 769396
10 EX-101.PRE aytu-20220930_pre.xml EX-101.PRE 702663
135 EXTRACTED XBRL INSTANCE DOCUMENT aytu-20220930x10qa_htm.xml XML 2617352
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q/A | Act: 34 | File No.: 001-38247 | Film No.: 23648580
SIC: 2834 Pharmaceutical Preparations